• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Surges Over 100 Points; Netflix Shares Slide After Q1 Results

    4/19/24 9:55:13 AM ET
    $AGBA
    $EGOX
    $ISPC
    $NFLX
    Investment Managers
    Finance
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $AGBA alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones index gaining over 100 points on Friday.

    Following the market opening Friday, the Dow traded up 0.30% to 37,889.94 while the NASDAQ fell 0.58% to 15,510.91. The S&P 500 also fell, dropping, 0.12% to 5,005.11.

    Check This Out: Jim Cramer Is ‘Willing To Let This Pharma Stock Catch Fire,’ Advises Not To Sell McKesson

    Leading and Lagging Sectors

    Energy shares climbed by 1% on Friday.

    In trading on Friday, communication services shares fell by1.2%.

    Top Headline

    Shares of Netflix, Inc. (NASDAQ:NFLX) fell around 8% during Friday's session following first-quarter results.

    Netflix reported upbeat earnings and sales results for its first quarter. The company added 9.33 million paid net new subscribers in the first quarter to bring the company to a total of 269.60 million.

    Equities Trading UP
                           

    • Next.e.GO N.V. (NASDAQ:EGOX) shares shot up 115% to $0.0740.
    • Shares of Zhongchao Inc. (NASDAQ:ZCMD) got a boost, surging 48% to $2.14.
    • AGBA Group Holding Limited (NASDAQ:AGBA) shares were also up, gaining 40% to $1.4399 on continued upward momentum after the company announced it entered into a definitive merger agreement with Triller.

    Equities Trading DOWN

    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) shares dropped 37% to $2.08. Sunshine Biopharma’s Nora Pharma received Health Canada approval for Niopeg.
    • Shares of iSpecimen Inc. (NASDAQ:ISPC) were down 28% to $0.30.
    • Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) was down, falling 21% to $0.63.

    Also Check This Out: Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling

    Commodities

    In commodity news, oil traded down 1% to $81.90 while gold traded down 0.3% at $2,390.00.

    Silver traded down 0.4% to $28.265 on Friday, while copper rose 0.5% to $4.4595.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 declined 0.5%, London's FTSE 100 fell 0.7% while Spain's IBEX 35 Index declined 0.7% The German DAX fell 0.7% French CAC 40 fell 0.3% while Italy's FTSE MIB Index slipped 0.3%.

    Spain’s trade gap narrowed to EUR 2.4 billion in February from EUR 2.5 billion in the year-ago month, while Spain’s consumer confidence indicator climbed to 82.5 in March from 78.5 in February.

    Producer prices in Germany fell by 2.9% year-over-year in March compared to a 4.1% decline in the prior month, while retail sales volumes in the UK came in flat for March.

    Asia Pacific Markets

    Asian markets closed mostly lower on Friday, with Japan's Nikkei 225 dipping 2.66%, Hong Kong's Hang Seng Index falling 0.99%, China's Shanghai Composite falling 0.29% and India's S&P BSE Sensex gaining 0.83%.

    Foreign direct investment into China declined by 26.1% year-over-year to CNY 301.67 billion in the first quarter. The business confidence indicator in Hong Kong rose to +2 in the second quarter of from +1 in the prior three-month period. The core consumer price index in Japan increased 2.6% year-over-year in March from 2.8% in February.

    Economics

    The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.

    Now Read This: How To Earn $500 A Month From Innovative Industrial Properties Stock

    Get the next $AGBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGBA
    $EGOX
    $ISPC
    $NFLX

    CompanyDatePrice TargetRatingAnalyst
    Netflix Inc.
    $NFLX
    1/23/2026$150.00 → $120.00Outperform
    Robert W. Baird
    Netflix Inc.
    $NFLX
    1/21/2026$115.00 → $112.00Buy
    TD Cowen
    Netflix Inc.
    $NFLX
    1/21/2026$121.00 → $95.00Outperform
    Wolfe Research
    Netflix Inc.
    $NFLX
    1/21/2026$145.00 → $120.00Buy
    Rothschild & Co Redburn
    Netflix Inc.
    $NFLX
    1/21/2026$152.00 → $125.00Buy
    Canaccord Genuity
    Netflix Inc.
    $NFLX
    1/21/2026$110.00 → $108.00Overweight
    KeyBanc Capital Markets
    Netflix Inc.
    $NFLX
    1/21/2026$120.00 → $110.00Overweight
    Morgan Stanley
    Netflix Inc.
    $NFLX
    1/21/2026$112.00 → $100.00Neutral
    Goldman
    More analyst ratings

    $AGBA
    $EGOX
    $ISPC
    $NFLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Robert W. Baird reiterated coverage on Netflix with a new price target

    Robert W. Baird reiterated coverage of Netflix with a rating of Outperform and set a new price target of $120.00 from $150.00 previously

    1/23/26 10:17:50 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    TD Cowen reiterated coverage on Netflix with a new price target

    TD Cowen reiterated coverage of Netflix with a rating of Buy and set a new price target of $112.00 from $115.00 previously

    1/21/26 11:17:23 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Wolfe Research reiterated coverage on Netflix with a new price target

    Wolfe Research reiterated coverage of Netflix with a rating of Outperform and set a new price target of $95.00 from $121.00 previously

    1/21/26 11:17:23 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AGBA
    $EGOX
    $ISPC
    $NFLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TIAN RUIXIANG Holdings Ltd. Announces Results of Annual General Meeting and Approval of 1-for-50 Reverse Share Split

    BEIJING, Feb. 18, 2026 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX) (the "Company") today announced the results of its annual general meeting of shareholders (the "AGM") held on February 17, 2026. At the AGM, the Company's shareholders approved, among other things: 1.   An increase in the Company's authorized share capital to US$3,750,000,000; and 2.   The grant of authority to the Board of Directors to effect a reverse share split at a ratio between 1-for-2 and 1-for-5,000. Implementation of Reverse Share Split Following the AGM, the Company's Board of Directors has approved the implementation of a reverse share split of its ordinary shares at a ratio of 1-for-50 (t

    2/18/26 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    WBD Files Definitive Proxy Statement and Schedules Special Meeting for March 20, 2026, to Approve the WBD-Netflix Transaction

    The WBD-Netflix Transaction Delivers Incredible Value and Certainty to WBD Stockholders with Clear Path to Timely Regulatory ApprovalNetflix is the Superior Deal and the Only Deal Before WBD Stockholders  Together WBD and Netflix will Protect U.S. Jobs, Bring Great Value to Consumers and Assure Growth of the Broader Entertainment IndustryA PSKY transaction does not have an easier or faster path to regulatory approval and PSKY's financing challenges and rapid deleveraging plans pose tremendous risk to the entertainment industryHOLLYWOOD, Calif., Feb. 17, 2026 /CNW/ -- Netflix, Inc. today issued the following statement regarding its fully financed definitive agreement with Warner Bros. Discove

    2/17/26 7:03:00 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Warner Bros. Discovery Sets Special Meeting Date of March 20, 2026, and Unanimously Recommends Shareholders Vote FOR Netflix Merger; Warner Bros. Discovery to Initiate Discussions with Paramount Skydance for Their Best and Final Offer

    Netflix Grants Seven-Day Waiver Permitting WBD to Engage with PSKY Regarding Deficiencies and Open Items in Amended Offer PSKY Representative Separately Informed WBD it Would Agree to Pay $31 Per Share Pending Engagement and That the Offer Was Not PSKY's "Best and Final" ProposalNEW YORK, Feb. 17, 2026 /PRNewswire/ -- Warner Bros. Discovery, Inc. ("WBD") (NASDAQ:WBD) today announced that it will hold the Special Meeting of Shareholders (the "Special Meeting") to vote on the merger with Netflix, Inc. ("Netflix") (NASDAQ:NFLX) on March 20, 2026 at 8:00 a.m. Eastern Time and the commencement of mailing of the definitive proxy statement to shareholders in connection with the Special Meeting. WBD

    2/17/26 7:00:00 AM ET
    $NFLX
    $PSKY
    $WBD
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Broadcasting
    Industrials

    $AGBA
    $EGOX
    $ISPC
    $NFLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Slilaty Steve N. bought $10,000 worth of Series B Preferred Stock (100,000 units at $0.10), increasing direct ownership by 333% to 130,000 units (SEC Form 4)

    4 - Sunshine Biopharma, Inc (0001402328) (Issuer)

    3/5/24 4:05:35 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Slilaty Steve N. bought $2,000 worth of Series B Preferred Stock (20,000 units at $0.10), increasing direct ownership by 200% to 30,000 units (SEC Form 4)

    4 - Sunshine Biopharma, Inc (0001402328) (Issuer)

    2/12/24 4:05:15 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $EGOX
    $ISPC
    $NFLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Hyman David A sold $464,231 worth of shares (5,727 units at $81.06), decreasing direct ownership by 2% to 316,100 units (SEC Form 4)

    4 - NETFLIX INC (0001065280) (Issuer)

    2/11/26 5:43:54 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Chief Global Affairs Officer Willems Cletus R sold $259,253 worth of shares (3,136 units at $82.67), closing all direct ownership in the company (SEC Form 4)

    4 - NETFLIX INC (0001065280) (Issuer)

    2/11/26 5:43:39 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Co-CEO Peters Gregory K sold $2,273,454 worth of shares (27,312 units at $83.24), decreasing direct ownership by 18% to 122,140 units (SEC Form 4)

    4 - NETFLIX INC (0001065280) (Issuer)

    2/11/26 5:43:47 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AGBA
    $EGOX
    $ISPC
    $NFLX
    SEC Filings

    View All

    Sunshine Biopharma Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Sunshine Biopharma Inc. (0001402328) (Filer)

    2/20/26 4:08:43 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form PRE 14C filed by Sunshine Biopharma Inc.

    PRE 14C - Sunshine Biopharma Inc. (0001402328) (Filer)

    2/20/26 4:05:18 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    iSpecimen Inc. filed SEC Form 8-K: Other Events

    8-K - iSpecimen Inc. (0001558569) (Filer)

    2/18/26 4:30:19 PM ET
    $ISPC
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AGBA
    $EGOX
    $ISPC
    $NFLX
    Leadership Updates

    Live Leadership Updates

    View All

    TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

    BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

    5/30/25 6:10:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

    FORT LAUDERDALE, FL / ACCESSWIRE / January 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals is pleased to announce the appointment of Mr. Michel Roy as its new Chief Commercial Officer (CCO), effective immediately. Mr. Roy brings a wealth of experience and a proven track record of success in driving commercial growth and strategic initiatives.In this role, Mr. Roy will be responsible for overseeing the Company's commercial strategy, including sales, marketing, and business development. With over 20 years of experience in the pharmaceutic

    1/15/25 8:00:00 AM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AGBA Group, one of Nasdaq's top 10 best-performing stocks for 2024, further cements strategic partnership with Yorkville

    LOS ANGELES, July 05, 2024 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited ("AGBA" or the "Company" or the "Group"), entered into an Amended and Restated Standby Equity Purchase Agreement ("A&R SEPA") with YA II PN, LTD, a Cayman Islands exempt limited partnership ("Yorkville"), and Triller. This development marks another important milestone as the merger of AGBA and Triller enters its final phase of completion. It also further cements the strategic relationship between AGBA and Yorkville, a leading global investment fund providing growth and acquisition capital to public companies. The revised arrangement is a vote of confidence and widens the range of financing an

    7/5/24 9:00:00 AM ET
    $AGBA
    Investment Managers
    Finance

    $AGBA
    $EGOX
    $ISPC
    $NFLX
    Financials

    Live finance-specific insights

    View All

    PARAMOUNT LAUNCHES All-CASH TENDER OFFER TO ACQUIRE WARNER BROS. DISCOVERY FOR $30 PER SHARE

    Offer provides superior value, and a more certain and quicker path to completion to WBD shareholdersEquity to be backstopped by Ellison Family and RedBird Capital in addition to debt fully committed by Bank of America, Citi and ApolloObligation to take offer directly to WBD shareholders over concerns they were not presented most compelling and superior transactionNetflix transaction provides WBD shareholders with inferior and uncertain value, a protracted and uncertain multi-jurisdictional regulatory clearance process, a complex and volatile mix of equity and cash, and ownership of Global Networks as a standalone overleveraged company whose future trading value is uncertainLOS ANGELES and NE

    12/8/25 9:02:00 AM ET
    $NFLX
    $PSKY
    $WBD
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Broadcasting
    Industrials

    Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, "From Traditional Insurance Broker to Tech-Based Health Insurance Innovator"

    ST. PETERSBURG, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ:TIRX) titled, "From Traditional Insurance Broker to Tech- Based Health Insurance Innovator". The report can be accessed here. Access to China's growing health insurance market. On June 30, 2025, Chinese insurance broker Tian Ruixiang Holdings Limited completed the acquisition of Ucare, which describes itself as the only cloud-based healthcare value assessment and insurance risk control SaaS platform in China, for total all-stock consideration of $150 million. Ucare's wealth of AI-driven analytics st

    8/7/25 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Completes Acquisition of Ucare Inc., Marking Strategic Expansion into AI-Powered Health Insurance Solutions

    BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX's strategy to expand into in-hospital distribution channels and capture new growth opportunities within the health insurance sector. As part of the closing, TRX has issued 101,486,575 Class A ordinary shares, each with a par value of US$0.025

    6/30/25 3:05:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    $AGBA
    $EGOX
    $ISPC
    $NFLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sunshine Biopharma Inc.

    SC 13G/A - Sunshine Biopharma Inc. (0001402328) (Subject)

    11/14/24 4:28:14 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by TIAN RUIXIANG Holdings Ltd

    SC 13G/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    11/13/24 11:16:48 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D filed by TIAN RUIXIANG Holdings Ltd

    SC 13D - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:15:45 AM ET
    $TIRX
    Specialty Insurers
    Finance